A recent retrospective study published in CHEST evaluated the effects of cystic fibrosis transmembrane conductance regulator ...

Arcturus Therapeutics (ARCT) had a challenging fourth quarter, with revenue and earnings falling short of analyst ...

Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved by the Medicines and Healthcare ...

This year, the Superdance went above and beyond its fundraising goal. “We had an original goal of $150,000. But as of ...

Proimos discusses his former aftermarket career at AP Emissions Technologies and the next facet of his life that supports ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...

A 19-year-old with cystic fibrosis (CF) is aiming to run the London Marathon to raise money for charity and awareness for the ...

In two randomised phase 3 studies involving 480 participants aged 12 years and over, ivacaftor/tezacaftor/vanzacaftor was ...

The 11th annual Butte Cystic Fibrosis NCAA Basketball Calcutta will be March 19 at the Butte Country Club. The event gets underway at 5:30 p.m. and although the public is welcome, you must be 18 or ...

Vertex Pharmaceuticals (NasdaqGS:VRTX) announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its market ...

A recent retrospective study published in CHEST(Opens in a new window) evaluated the effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulator use on pregnancy outcomes in ...